Biology Reference
In-Depth Information
S., Schade, U. F., Di Padova, F., Kusumoto, S. and Schumann, R. R. (1996).
Bacterial endotoxin: chemical constitution, biological recognition, host response,
and immunological detoxification. In
Pathology of Septic Shock
, ed. by Reitschel,
E. T. and Wagner, H., Springer: New York, pp 39-81.
Rietschel, E. T. and Westphal, O. (1999). Endotoxin: historical perspectives. In
Endotoxin in Health and Disease
, ed. by Brade, H., Opal, S., Vogel, S. N. and
Morrison, D. C., Marcel Dekker, Inc.: New York, pp. 1-30.
Rinehart, J., Balcerzak, S. and Hersh, M., (1990). Phase II trial of tumor necrosis factor in
human sarcoma,
Proc. Am. Soc. Clin. Oncol
., 9, pp. 317 (abstr 1229).
Roberts, F. J., Geere, I. W. and Coldman, A (1991). A three-year study of positive blood
cultures, with emphasis on prognosis,
Rev. Infect. Dis.
,
13, pp. 34-46.
Rosenblum, M., Cheung, L., Murray, J. and Bartholomew, R. (1991). Antibody-mediated
delivery of tumor necrosis factor (TNF-α): improvement of cytotoxicity and
reduction of cellular resistance,
Cancer Commun
., 3, pp. 21-27.
Rossignol, D. and Lynn, M. (2005). TLR4 antagonists for endotoxemia and beyond,
Curr. Opin. Inv. Drugs
, 6, pp. 496-502.
Rudolphi, K., Gerwin, N., Verzijl, N., van der Kraan, P., and van den Berg, W. (2003).
Pralnacasan, an inhibitor of interleukin-1β converting enzyme, reduces joint
damage in two murine models of osteoarthritis,
Osteoart. Cartilage
, 11, pp. 738-
746.
Ruegg, C., Yilmaz, A., Bieler, G., Bamat, J., Chaubert, P. and Lejeune, F. (1998).
Evidence for the involvement of endothelial cell integrin αVβ3 in the disruption of
the tumor vasculature induced by TNF and IFN-γ,
Nat. Med.
, 4, pp. 408-414.
Ryu, J., Son, H., Lee, S. and Sohn, D. (2002). Two neolignans from Perilla frutescens and
their inhibition of nitric oxide synthase and tumor necrosis factor-α expression in
murine macrophage cell line Raw 264.7,
Bioorg. Med. Chem. Lett.
, 12, pp. 649-
651.
Sacchi, A., Gasparri, A., Gallo-Stampino, C., Toma, S., Curnis, F. and Corti, A. (2006).
Synergistic antitumor activity of cisplatin, paclitaxel, and gemcitabine with tumor
vasculature-targeted tumor necrosis factor-α,
Clin. Cancer. Res.
, 12, pp. 175-182.
Sakagami, H., Asano, K., Tanuma, S., Hatano, T., Yoshida, T. and Okuda, T. (1992).
Stimulation of monocyte iodination and IL-1 production by tannins and related
compounds,
Anticancer Res
., 12, pp. 377-387.
Sakagami, H., Jiang, Y., Kusama, K., Atsumi, T., Ueha, T., Toguchi, M., Iwakura, I.,
Satoh, K., Ito, H., Hatano, T. and Yoshida, T. (2000). Cytotoxic activity of
hydrolyzable tannins against human oral tumor cell lines - A possible mechanism,
Phytochemistry
, 7, pp. 39-47.
Sampaio, E., Sarno, E., Galilly, R., Cohn, Z. and Kaplan, G. (1991). Thalidomide
selectively inhibits tumor necrosis factor alpha production by stimulated human
monocytes,
J. Exp. Med.
, 173, pp. 699-703.
Schumann, R., Leong, S., Flaggs, G., Gray, P., Wright, S., Mathison, J., Tobias, P. and
Ulevitch, R. (1990). Structure and function of lipopolysaccharide binding protein,
Science
, 249, pp. 1429-1431.
Schumann, R. and Zweigner, J. (1999). A novel acute-phase marker. Lipopolysaccharide
binding protein (LBP),
Clin. Chem. Lab. Med.
, 37, pp. 271-274.
